SA07280317B1 - مستحضرات توليفية تشتمل على slv308 وl – dopa - Google Patents
مستحضرات توليفية تشتمل على slv308 وl – dopa Download PDFInfo
- Publication number
- SA07280317B1 SA07280317B1 SA7280317A SA07280317A SA07280317B1 SA 07280317 B1 SA07280317 B1 SA 07280317B1 SA 7280317 A SA7280317 A SA 7280317A SA 07280317 A SA07280317 A SA 07280317A SA 07280317 B1 SA07280317 B1 SA 07280317B1
- Authority
- SA
- Saudi Arabia
- Prior art keywords
- treatment
- dopa
- dopamine
- slv308
- oral
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06115583 | 2006-06-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SA07280317B1 true SA07280317B1 (ar) | 2010-09-29 |
Family
ID=37513845
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SA7280317A SA07280317B1 (ar) | 2006-06-16 | 2007-06-13 | مستحضرات توليفية تشتمل على slv308 وl – dopa |
Country Status (7)
| Country | Link |
|---|---|
| CN (1) | CN101516371A (zh) |
| AR (1) | AR061355A1 (zh) |
| BR (1) | BRPI0713695A2 (zh) |
| MX (1) | MX2008016225A (zh) |
| SA (1) | SA07280317B1 (zh) |
| TW (1) | TW200813038A (zh) |
| UA (1) | UA94466C2 (zh) |
-
2007
- 2007-06-13 SA SA7280317A patent/SA07280317B1/ar unknown
- 2007-06-13 AR ARP070102580A patent/AR061355A1/es not_active Application Discontinuation
- 2007-06-13 TW TW096121305A patent/TW200813038A/zh unknown
- 2007-06-15 BR BRPI0713695-1A patent/BRPI0713695A2/pt not_active IP Right Cessation
- 2007-06-15 UA UAA200900253A patent/UA94466C2/ru unknown
- 2007-06-15 MX MX2008016225A patent/MX2008016225A/es not_active Application Discontinuation
- 2007-06-15 CN CNA2007800225200A patent/CN101516371A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AR061355A1 (es) | 2008-08-20 |
| MX2008016225A (es) | 2009-01-19 |
| UA94466C2 (ru) | 2011-05-10 |
| CN101516371A (zh) | 2009-08-26 |
| BRPI0713695A2 (pt) | 2012-10-30 |
| TW200813038A (en) | 2008-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Vijayakumar et al. | Drug-induced dyskinesia, part 1: treatment of levodopa-induced dyskinesia | |
| JP5953000B2 (ja) | Ｃｍｔ及び関連疾患の処置のための新規な治療的アプローチ | |
| JP2008519847A (ja) | 運動障害の治療方法 | |
| US9415030B2 (en) | High-dose glycine as a treatment for obsessive-compulsive disorder and obsessive-compulsive spectrum disorders | |
| JP2024050575A (ja) | Ｌ－４－クロロキヌレニンの治療的使用 | |
| BR112020004622A2 (pt) | pridopidina para tratamento de discinesias induzidas por droga | |
| WO2008049157A1 (en) | Combination therapy | |
| CA2654557A1 (en) | Combination preparations comprising bifeprunox and l-dopa | |
| US20200069672A1 (en) | Methods of using a phenoxypropylamine compound to treat pain | |
| CA2966879A1 (en) | Methods of treating huntington's disease using cysteamine compositions | |
| US10512637B2 (en) | Use of inhibitor of cystine-glutamate transporter | |
| US7786126B2 (en) | Combination preparations comprising SLV308 and a dopamine agonist | |
| SA07280317B1 (ar) | مستحضرات توليفية تشتمل على slv308 وl – dopa | |
| CA2654719A1 (en) | Combination preparations comprising slv308 and a l-dopa | |
| RS66934B1 (sr) | Jedinjenja za upotrebu u lečenju poremećaja pažnje sa hiperaktivnošću | |
| SA07280316B1 (ar) | مستحضرات توليفية تشتمل على bifeprunox وL – DOPA | |
| US8106056B2 (en) | Combination preparations comprising bifeprunox and a dopamine agonist | |
| HK1135017A (zh) | 包括slv308和左旋多巴的组合制剂 | |
| HK1130677A (zh) | 包含联苯芦诺和左旋多巴的组合制剂 | |
| JP2008545616A (ja) | ジスキネジーの阻害または治療 |